Pharmacologic Stabilization of Retromer Rescues Endosomal Pathology Induced by Defects in the Alzheimer's gene SORL1
Mishra, S.; Knupp, A.; Kinoshita, C.; Martinez, R.; Theofilas, P.; Young, J. E.
Show abstract
The Sortilin-related receptor 1 gene (SORL1, SORLA) is strongly associated with risk of developing Alzheimers disease (AD). SORLA is a regulator of endosomal trafficking in neurons and interacts with retromer, a complex that is a master conductor of endosomal trafficking. Pharmacological chaperones stabilize retromer in vitro, enhancing its function. Here we used an isogenic series of human induced pluripotent stem cell (hiPSC) lines with either one or two copies of SORL1 or harboring one copy of a SORL1 variant linked to increased risk for AD. We treated hiPSC-derived cortical neurons with the established retromer chaperone, TPT-260, and tested whether indicators of ADs defining endosomal, amyloid, and Tau pathologies were corrected. We observed that the degree of rescue by TPT-260 treatment varied, depending on the number of copies of functional SORL1 and which SORL1 variant was expressed. Using a disease-relevant preclinical model, our work illuminates how the SORL1-retromer pathway can be therapeutically harnessed.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Aβ-driven nuclear pore complex dysfunction alters activation of necroptosis proteins in a mouse model of Alzheimer's Disease 96%
- Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model 96%
- Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of Huntingtin 96%
Similar papers in this journal
- HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFs 96%
- Extracellular tau clearance is governed by its aggregation state and independent of microglial activation by LPS and IFN-γ 94%
- A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity 94%
Similar papers in this journal
- Increased neuronal expression of the early endosomal adaptor APPL1 replicates Alzheimer's Disease-related endosomal and synaptic dysfunction with cholinergic neurodegeneration 96%
- ZCCHC17 modulates neuronal RNA splicing and supports cognitive resilience in Alzheimer's disease 96%
- Amelioration of symptomatic Alzheimer's Disease after selective impairment of p75NTR function in adult forebrainexcitatory neurons 96%
Similar papers in this journal
- Depletion of the AD risk gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic APP processing 96%
- Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson's disease 95%
- Clearing truncated tau protein restores neuronal function and prevents microglia activation in tauopathy mice 94%
Similar papers in this journal
- Suppression of amyloid-β secretion from neurons by cis-9, trans-11-octadecadienoic acid, an isomer of conjugated linoleic acid 95%
- Troriluzole Rescues Glutamatergic Deficits, Amyloid and Tau Pathology, and Synaptic and Memory Impairments in 3xTg-AD Mice 94%
- Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.